Circulating progenitor cells are reduced in patients with severe lung disease

Stem Cells

Volumn 24, Issue 7, 2006, Pages 1806-1813

  Fadini, Gian Paolo ^a,c   Schiavon, Marco ^a   Cantini, Marcella ^b   Baesso, Ilenia ^a   Facco, Monica ^a   Miorin, Marta ^a   Tassinato, Mauro ^a   De Kreutzenberg, Saula Vigili ^a   Avogaro, Angelo ^a   Agostini, Carlo ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b Social Pneumology Service   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Endothelial dysfunction; Endothelial progenitor cells; Pulmonary disease; Stem cells

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD CELL COUNT; BLOOD GAS ANALYSIS; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; ENDOTHELIUM CELL; ERYTHROCYTE COUNT; FEMALE; HUMAN; HYPOXIA; LUNG VOLUME; MALE; SPIROMETRY; STEM CELL; BLOOD; CASE CONTROL STUDY; CHRONIC DISEASE; HYPOXEMIA; LUNG DISEASE; MIDDLE AGED; PATHOLOGY; SMOKING; VASCULAR ENDOTHELIUM;

AGED; ANOXEMIA; BLOOD CELL COUNT; CASE-CONTROL STUDIES; CHRONIC DISEASE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LUNG DISEASES; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; SMOKING; STEM CELLS;

EID: 33747431983     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2005-0440     Document Type: Article

References (57)

1. Hopkins N, McLoughlin P. The structural basis of pulmonary hypertension in chronic lung disease: Remodelling, rarefaction or angiogenesis? J Anat 2002;201:335-348.
2. Dorfmuller P, Humbert M, Capron F et al. Pathology and aspects of pathogenesis in pulmonary arterial hypertension. Sarcoidosis Vasc Diffuse Lung Dis 2003;20:9-19.
3. Keane MP. Angiogenesis and pulmonary fibrosis: Feast or famine? Am J Respir Crit Care Med 2004;170:207-209.
4. Renzoni EA. Neovascularization in idiopathic pulmonary fibrosis: Too much or too little? Am J Respir Crit Care Med 2004;169:1179-1180.
5. Chaouat A, Bugnet AS, Kadaoui N et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;172:189-194.
6. Barbera JA, Peinado VI, Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J 2003;21:892-905.
7. Howell K, Preston RJ, McLoughlin P. Chronic hypoxia causes angiogenesis in addition to remodelling in the adult rat pulmonary circulation. J Physiol 2003;547:133-145.
8. Molthen RC, Karau KL, Dawson CA. Quantitative models of the rat pulmonary arterial tree morphometry applied to hypoxia-induced arterial remodeling. J Appl Physiol 2004;97:2372-2384.
9. Meyrick B, Reid L. The effect of continued hypoxia on rat pulmonary arterial circulation. An ultrastructural study. Lab Invest 1978;38:188-200.
10. Budhiraja R, Tuder RM, Hassoun PM. Endothelial dysfunction in pulmonary hypertension. Circulation 2004;109:159-165.
11. Cella G, Bellotto F, Tona F et al. Plasma markers of endothelial dysfunction in pulmonary hypertension. Chest 2001;120:1226-1230.
12. Taraseviciene-Stewart L, Kasahara Y, Alger L et al. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J 2001;15:427-438.
13. Murata T, Hori M, Sakamoto K et al. Dexamethasone blocks hypoxia-induced endothelial dysfunction in organ-cultured pulmonary arteries. Am J Respir Crit Care Med 2004;170:647-655.
14. Humbert M, Morrell NW, Archer SL et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:13S-24S.
15. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 2004;351:1655-1665.
16. Malmstrom RE, Tornberg DC, Settergren G et al. Endogenous nitric oxide release by vasoactive drugs monitored in exhaled air. Am J Respir Crit Care Med 2003;168:114-120.
17. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967.
18. Crosby JR, Kaminski WE, Schatteman G et al. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res 2000;87:728-730.
19. Cho HJ, Kim HS, Lee MM et al. Mobilized endothelial progenitor cells by granulocyte-macrophage colony stimulating factor accelerate reendothelization and reduce vascular inflammation after intravascular radiation. Circulation 2003;108:2918-2925.
20. Urbich C, Dimmeler S. Endothelial progenitor cells: Characterization and role in vascular biology. Circ Res 2004;95:343-353.
21. Peichev M, Naiyer AJ, Pereira D et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identify a population of functional endothelial precursors. Blood 2000;95:952-958.
22. Takahashi T, Kalka C, Masuda H et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434-438.
23. Hill JM, Zalos G, Halcox JP et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600.
24. Cella G, Sbarai A, Mazzaro G et al. Plasma markers of endothelial dysfunction in chronic obstructive pulmonary disease. Clin Appl Thromb Hemost 2001;7:205-208.
25. Ferguson GT. Recommendations for the management of COPD. Chest 2000;117:23S-8S.
26. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002;165:277-304.
27. Kondo T, Hayashi M, Takeshida K et al. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 2004;24:1-6.
28. Lambiase PD, Edwards RJ, Anthopoulos P et al. Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support. Circulation 2004;109:2993-2999.
29. Kravtsov VD, Daniel TO, Koury MJ. Comparative analysis of different methodological approaches to the in vitro study of drug-induced apoptosis. Am J Pathol 1999;155:1327-1339.
30. Landmesser U, Hornig B, Drexler H. Endothelial function: A critical determinant in atherosclerosis? Circulation 2004;109:1127-1133.
31. Peinado VI, Santos S, Ramirez J et al. Response to hypoxia of pulmonary arteries in chronic obstructive pulmonary disease: An in vitro study. Eur Respir J 2002;20:332-338.
32. Khan SS, Solomon MA, McCoy JP. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin Cytom 2005;64:1-8.
33. Lee KW, Lip GYH, Tayebjee M et al. Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes. Blood 2005;105:526-532.
34. Hunninghake DB. Cardiovascular disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2:44-49.
35. Del Papa N, Colombo G, Fracchiolla N et al. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis. Arthritis Rheum 2004;50:1296-1304.
36. Bahlmann FH, De Groot K, Spandau JM et al. Erythropoietin regulates endothelial progenitor cells. Blood 2004;103:921-926.
37. Heeschen C, Aicher A, Lehmann R et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 2003;102:1340-1346.
38. Willemse BW, Ten Hacken NT, Rutgers B et al. Association of current smoking with airway inflammation in chronic obstructive pulmonary disease and asymptomatic smokers. Respir Res 2005;6:38.
39. Selman M. The spectrum of smoking-related interstitial lung disorders. Chest 2003;124:1184-1187.
40. Heiss C, Keymel S, Niesler U et al. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 2005;45:1441-1448.
41. Epperly MW, Guo H, Gretton JE et al. Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. Am J Respir Cell Mol Biol 2003;29:213-224.
42. Suratt BT, Cool CD, Serls AE et al. Human pulmonary chimerism after hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2003;168:318-322.
43. Abe S, Boyer C, Liu X et al. Cells derived from the circulation contribute to the repair of lung injury. Am J Respir Crit Care Med 2004;170:1158-1163.
44. Ebina M, Shimizukawa M, Shibata N et al. Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2004;169:1203-1208.
45. Neuringer IP, Randell SH. Stem cells and repair of lung injuries. Respir Res 2004;20:5:6.
46. Hashimoto N, Jin H, Liu T et al. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 2004;113:243-252.
47. Phillips RJ, Burdick MD, Hong K et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004;114:438-446.
48. Akita T, Murohara T, Ikeda H et al. Hypoxic preconditioning augments efficacy of human endothelial progenitor cells for therapeutic neovascularization. Lab Invest 2003;83:65-73.
49. Yamada M, Kubo H, Ishizawa K et al. Increased circulating endothelial progenitor cells in patients with bacterial pneumonia: Evidence than bone marrow derived cells contribute to lung repair. Thorax 2005;60:410-413.
50. Burnham EL, Taylor WR, Quyyumi AA et al. Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. Am J Respir Crit Care Med 2005;172:854-860.
51. Rojas M, Xu J, Woods CR et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005;33:145-152.
52. Santos S, Peinado VI, Ramirez J et al. Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:1250-1256.
53. Koyama S, Sato E, Haniuda M et al. Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis. Am J Respir Crit Care Med 2002;166:382-385.
54. Peinado V, Ramirez J, Roca J et al. Identification of vascular progenitor cells in pulmonary arteries of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2006;34:257-263.
55. Nagaya N, Kangawa K, Kanda M et al. Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells. Circulation 2003;108:889-895.
56. Takahashi M, Nakamura T, Toba T et al. Transplantation of endothelial progenitor cells into the lung to alleviate pulmonary hypertension in dogs. Tissue Eng 2004;10:771-779.
57. Zhao YD, Courtman DW, Deng Y et al. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: Efficacy of combined cell and eNOS gene therapy in established disease. Circ Res 2005;96:442-450.